KLK3 and posterior cortical atrophy: While the National Institute for Health and Care Excellence (NICE) suggests that DRE is sufficient as a referral standard for PCa suspicion, guidelines from the National Comprehensive Cancer Network (NCCN) propose DRE solely for men with high PSA [6,7].